CATS (Container Automated Tracking System)

Dayton, OH Feb 9, 2016 – Determining the optimum lease arrangements for active RKN containers and keeping track of a leased RKN portfolio can be a real headache for logistics companies shipping biologics and other temperature-sensitive products. Using the new CATS Customer Portal from CSafe allows container lessees to manage and oversee their RKN inventory from the comfort of their desks. The CATS data system allows authorized users instant and unlimited access to RKN log file decryption and charts at no cost.
Nearly two years in the making, the innovative CATS customer portal provides users with at-a-glance lease status including active and historical container status, RKN service history, testing/certification data and temperature verification dates as well as a host of industry and CSafe product information including user manuals and relevant SOPs.
Mark Mohr, CSafe Global’s Director of Customer Support and Partner Management says, “Access to the information in real-time closes the loop in the data chain when it comes to track and trace and regulatory compliance. By accessing validation and conformance data housed within the CATS system, CSafe authorized users can be assured of the quality of the equipment under lease.”
All customer account information is held on a secure server as encrypted data which is available for download as pre-formatted and ad-hoc reports as well as charts for offline analysis, processing and action. Content access can be controlled on an individual level, allowing restriction of user access to content based on specific business requirements.
“In developing the CATS system we listened to the advice from our MLA partners to ensure it was as useful and user-friendly as possible,” says Mr. Mohr. “The system has been thoroughly beta-tested with select customers over an eight-month period to ensure it is intuitive to use, secure and bug-free.”
Unlimited access to the CATS Container Automated Tracking System is free of charge to all CSafe Global’s Master Lease Agreement holders.

CMP Pharma and Generic Specialty Pharma Sign Product Development Agreement

Farmville, NC Feb 5, 2016 – CMP Pharma, Inc. of Farmville, NC and Generic Specialty Pharma Ltd. (GSP) of Dublin, Ireland have reached an agreement to partner on the development of a new prescription product (NDA). The product under development will be available in a sterile vial and represents CMP’s first product in an injectable dosage form.
Commenting on the agreement, CMP Pharma’s CEO Gerald Sakowski said “This agreement reinforces our commitment to bring new niche products to market. We are pleased that this product provides CMP a unique opportunity to expand into a new dosage form area while at the same time provides an important product to our current acute care customer base”.
CMP Pharma is a specialty pharmaceutical company located in Farmville, NC that develops and manufactures a portfolio of high-value topical and oral liquid pharmaceutical products. The company was founded in the early 1980s around the development of a ready-to-use liquid for sodium polystyrene sulfonate, a prescription drug used for the treatment of hyperkalemia.
Generic Specialty Pharma is a privately owned pharmaceutical company established in 2012, headquartered in Dublin, Ireland. GSP and its affiliates markets products through partners in more than 30 countries throughout the world with a strong focus on injectables.